• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment.

作者信息

Davoudi-Monfared Effat, Taghizadeh-Ghehi Maryam

机构信息

Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, 4th Floor, No 92, Karimkhan Zand Ave, Hafte Tir Sq, Tehran, Iran.

出版信息

Int J Clin Pharm. 2019 Jun;41(3):621-622. doi: 10.1007/s11096-019-00822-6. Epub 2019 Apr 9.

DOI:10.1007/s11096-019-00822-6
PMID:30963445
Abstract
摘要

相似文献

1
Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment.低剂量与高剂量多粘菌素治疗多重耐药性肺炎的成本效益分析：一则评论
Int J Clin Pharm. 2019 Jun;41(3):621-622. doi: 10.1007/s11096-019-00822-6. Epub 2019 Apr 9.
2
Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia.沙特阿拉伯低剂量与高剂量黏菌素治疗多重耐药性肺炎的成本效益分析。
Int J Clin Pharm. 2018 Oct;40(5):1051-1058. doi: 10.1007/s11096-018-0713-x. Epub 2018 Aug 16.
3
Cost-effective analysis of low- versus high-dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia.沙特阿拉伯低剂量与高剂量多粘菌素治疗多重耐药性肺炎的成本效益分析。
Int J Clin Pharm. 2019 Feb;41(1):1-2. doi: 10.1007/s11096-019-00783-w. Epub 2019 Jan 19.
4
Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae.多黏菌素单药与多黏菌素联合美罗培南治疗多重耐药肺炎克雷伯菌引起的医院获得性肺炎和呼吸机相关性肺炎的前瞻性、对照临床研究。
J Glob Antimicrob Resist. 2018 Dec;15:127-135. doi: 10.1016/j.jgar.2018.07.003. Epub 2018 Oct 11.
5
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.雾化多黏菌素用于治疗非囊性纤维化患者由多重耐药革兰阴性菌引起的医院获得性肺炎。
Crit Care. 2005 Feb;9(1):R53-9. doi: 10.1186/cc3020. Epub 2005 Jan 6.
6
Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.多药耐药鲍曼不动杆菌肺炎患者接受黏菌素治疗的死亡预测因素。
Int J Antimicrob Agents. 2016 Aug;48(2):175-80. doi: 10.1016/j.ijantimicag.2016.05.011. Epub 2016 Jul 5.
7
Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.替加环素与黏菌素治疗重症患者耐多药和广泛耐药鲍曼不动杆菌肺炎的疗效比较
PLoS One. 2016 Mar 2;11(3):e0150642. doi: 10.1371/journal.pone.0150642. eCollection 2016.
8
Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia.多粘菌素负荷剂量、高剂量维持方案治疗耐多药革兰阴性菌肺炎重症患者的疗效与安全性
J Intensive Care Med. 2017 Sep;32(8):487-493. doi: 10.1177/0885066616646551. Epub 2016 May 2.
9
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.多黏菌素联合治疗广泛耐药鲍曼不动杆菌肺炎。
Int J Antimicrob Agents. 2014 Apr;43(4):378-82. doi: 10.1016/j.ijantimicag.2014.01.016. Epub 2014 Feb 14.
10
Colistin combination therapy improves microbiologic cure in critically ill patients with multi-drug resistant gram-negative pneumonia.黏菌素联合治疗可提高耐多药革兰氏阴性菌肺炎重症患者的微生物清除率。
Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1433-9. doi: 10.1007/s10096-016-2681-1. Epub 2016 May 26.

本文引用的文献

1
Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia.沙特阿拉伯低剂量与高剂量黏菌素治疗多重耐药性肺炎的成本效益分析。
Int J Clin Pharm. 2018 Oct;40(5):1051-1058. doi: 10.1007/s11096-018-0713-x. Epub 2018 Aug 16.
2
Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.小剂量多黏菌素治疗多重耐药革兰阴性菌感染的疗效与安全性
J Clin Pharm Ther. 2014 Jun;39(3):272-6. doi: 10.1111/jcpt.12138. Epub 2014 Mar 5.
3
Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
大剂量静脉和雾化黏菌素治疗多重耐药鲍曼不动杆菌呼吸机相关性肺炎：我们真的需要这种治疗吗？
J Infect Chemother. 2012 Dec;18(6):872-7. doi: 10.1007/s10156-012-0430-7. Epub 2012 May 29.
4
Clinical and microbiological end points in the treatment of pneumonia.肺炎治疗中的临床和微生物学终点
Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S207-9. doi: 10.1086/591406.